311 related articles for article (PubMed ID: 12902985)
21. Hypermethylation of the GATA genes in lung cancer.
Guo M; Akiyama Y; House MG; Hooker CM; Heath E; Gabrielson E; Yang SC; Han Y; Baylin SB; Herman JG; Brock MV
Clin Cancer Res; 2004 Dec; 10(23):7917-24. PubMed ID: 15585625
[TBL] [Abstract][Full Text] [Related]
22. The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host.
Podhajcer OL; Benedetti L; Girotti MR; Prada F; Salvatierra E; Llera AS
Cancer Metastasis Rev; 2008 Sep; 27(3):523-37. PubMed ID: 18459035
[TBL] [Abstract][Full Text] [Related]
23. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
[TBL] [Abstract][Full Text] [Related]
24. Frequent inactivation of SPARC by promoter hypermethylation in colon cancers.
Yang E; Kang HJ; Koh KH; Rhee H; Kim NK; Kim H
Int J Cancer; 2007 Aug; 121(3):567-75. PubMed ID: 17397030
[TBL] [Abstract][Full Text] [Related]
25. SPARC enhances tumor stroma formation and prevents fibroblast activation.
Chlenski A; Guerrero LJ; Yang Q; Tian Y; Peddinti R; Salwen HR; Cohn SL
Oncogene; 2007 Jul; 26(31):4513-22. PubMed ID: 17260013
[TBL] [Abstract][Full Text] [Related]
26. Characterization of tumor-derived pancreatic stellate cells.
Farrow B; Rowley D; Dang T; Berger DH
J Surg Res; 2009 Nov; 157(1):96-102. PubMed ID: 19726060
[TBL] [Abstract][Full Text] [Related]
27. Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.
Taniguchi H; Yamamoto H; Hirata T; Miyamoto N; Oki M; Nosho K; Adachi Y; Endo T; Imai K; Shinomura Y
Oncogene; 2005 Nov; 24(53):7946-52. PubMed ID: 16007117
[TBL] [Abstract][Full Text] [Related]
28. TP53INP1 decreases pancreatic cancer cell migration by regulating SPARC expression.
Seux M; Peuget S; Montero MP; Siret C; Rigot V; Clerc P; Gigoux V; Pellegrino E; Pouyet L; N'Guessan P; Garcia S; Dufresne M; Iovanna JL; Carrier A; André F; Dusetti NJ
Oncogene; 2011 Jul; 30(27):3049-61. PubMed ID: 21339733
[TBL] [Abstract][Full Text] [Related]
29. Differential and epigenetic gene expression profiling identifies frequent disruption of the RELN pathway in pancreatic cancers.
Sato N; Fukushima N; Chang R; Matsubayashi H; Goggins M
Gastroenterology; 2006 Feb; 130(2):548-65. PubMed ID: 16472607
[TBL] [Abstract][Full Text] [Related]
30. Significant overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma using real-time quantitative reverse transcription polymerase chain reaction.
Nielsen A; Scarlett CJ; Samra JS; Gill A; Li Y; Allen BJ; Smith RC
J Gastroenterol Hepatol; 2005 Feb; 20(2):256-63. PubMed ID: 15683429
[TBL] [Abstract][Full Text] [Related]
31. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia.
Kang GH; Lee S; Lee HJ; Hwang KS
J Pathol; 2004 Feb; 202(2):233-40. PubMed ID: 14743506
[TBL] [Abstract][Full Text] [Related]
32. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
[TBL] [Abstract][Full Text] [Related]
33. The correlation between aberrant connexin 43 mRNA expression induced by promoter methylation and nodal micrometastasis in non-small cell lung cancer.
Chen JT; Cheng YW; Chou MC; Sen-Lin T; Lai WW; Ho WL; Lee H
Clin Cancer Res; 2003 Sep; 9(11):4200-4. PubMed ID: 14519646
[TBL] [Abstract][Full Text] [Related]
34. Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts.
Kaminski A; Hahne JC; Haddouti el-M; Florin A; Wellmann A; Wernert N
Int J Mol Med; 2006 Nov; 18(5):941-50. PubMed ID: 17016625
[TBL] [Abstract][Full Text] [Related]
35. Differential effect of Cyclosporin A and FK506 on SPARC mRNA expression by human gingival fibroblasts.
Gagliano N; Moscheni C; Torri C; Dellavia C; Stabellini G; Ferrario VF; Gioia M
Biomed Pharmacother; 2005 Jun; 59(5):249-52. PubMed ID: 15890490
[TBL] [Abstract][Full Text] [Related]
36. Hypoxic regulation of PFKFB-3 and PFKFB-4 gene expression in gastric and pancreatic cancer cell lines and expression of PFKFB genes in gastric cancers.
Bobarykina AY; Minchenko DO; Opentanova IL; Moenner M; Caro J; Esumi H; Minchenko OH
Acta Biochim Pol; 2006; 53(4):789-99. PubMed ID: 17143338
[TBL] [Abstract][Full Text] [Related]
37. Aberrant methylation of SPARC in human lung cancers.
Suzuki M; Hao C; Takahashi T; Shigematsu H; Shivapurkar N; Sathyanarayana UG; Iizasa T; Fujisawa T; Hiroshima K; Gazdar AF
Br J Cancer; 2005 Mar; 92(5):942-8. PubMed ID: 15756262
[TBL] [Abstract][Full Text] [Related]
38. Aberrant expression of SPARC and its impact on proliferation and apoptosis in ADPKD cyst-lining epithelia.
Wang W; Mei C; Tang B; Zhao H; Xu C; Li Z; Shen X; Fu W; Dai B
Nephrol Dial Transplant; 2006 May; 21(5):1278-88. PubMed ID: 16421164
[TBL] [Abstract][Full Text] [Related]
39. Aberrant methylation of the SPARC gene promoter and its clinical implication in gastric cancer.
Chen ZY; Zhang JL; Yao HX; Wang PY; Zhu J; Wang W; Wang X; Wan YL; Chen SW; Chen GW; Liu YC
Sci Rep; 2014 Dec; 4():7035. PubMed ID: 25516351
[TBL] [Abstract][Full Text] [Related]
40. The role of SPARC expression in pancreatic cancer progression and patient survival.
Gundewar C; Sasor A; Hilmersson KS; Andersson R; Ansari D
Scand J Gastroenterol; 2015; 50(9):1170-4. PubMed ID: 25765175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
